| |
| |
|
| Insider
Information: |
Mottiwala Aziz |
| Relationship: |
Chief Commercial Officer |
| City: |
Santa Monica |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
67,575 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$278,775 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
67,575 |
|
|
| Total
Value |
$278,775 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Opiant Pharmaceuticals Inc |
OPNT |
Officer |
2019-09-20 |
13,500 |
|
0 |
Premium* |
|
|
Tarsus Pharmaceuticals, Inc. |
TARS |
Chief Commercial Officer |
2024-03-18 |
54,075 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
23 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TARS |
Tarsus Pharmaceuticals, I... |
Chief Commercial Officer |
• – – |
2024-03-18 |
4 |
S |
$30.60 |
$145,840 |
D/D |
(4,766) |
54,075 |
0 |
- |
|
| TARS |
Tarsus Pharmaceuticals, I... |
Chief Commercial Officer |
• – – |
2024-03-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,938 |
58,841 |
0 |
- |
|
| TARS |
Tarsus Pharmaceuticals, I... |
Chief Commercial Officer |
• – – |
2023-07-19 |
4 |
AS |
$20.05 |
$48,120 |
D/D |
(2,400) |
45,806 |
0 |
- |
|
| TARS |
Tarsus Pharmaceuticals, I... |
Chief Commercial Officer |
• – – |
2023-06-08 |
4 |
AS |
$20.00 |
$2,000 |
D/D |
(100) |
48,086 |
0 |
- |
|
| TARS |
Tarsus Pharmaceuticals, I... |
Chief Commercial Officer |
• – – |
2023-06-07 |
4 |
AS |
$19.34 |
$48,350 |
D/D |
(2,500) |
48,186 |
0 |
- |
|
| TARS |
Tarsus Pharmaceuticals, I... |
Chief Commercial Officer |
• – – |
2023-06-06 |
4 |
AS |
$18.61 |
$39,881 |
D/D |
(2,143) |
50,686 |
0 |
- |
|
| TARS |
Tarsus Pharmaceuticals, I... |
Chief Commercial Officer |
• – – |
2023-03-23 |
4 |
S |
$12.15 |
$4,520 |
D/D |
(372) |
52,829 |
0 |
- |
|
| TARS |
Tarsus Pharmaceuticals, I... |
Chief Commercial Officer |
• – – |
2023-03-22 |
4 |
S |
$12.64 |
$4,512 |
D/D |
(357) |
53,201 |
0 |
- |
|
| TARS |
Tarsus Pharmaceuticals, I... |
Chief Commercial Officer |
• – – |
2023-03-21 |
4 |
S |
$12.89 |
$4,499 |
D/D |
(349) |
53,558 |
0 |
- |
|
| TARS |
Tarsus Pharmaceuticals, I... |
Chief Commercial Officer |
• – – |
2023-03-20 |
4 |
S |
$12.61 |
$4,514 |
D/D |
(358) |
53,907 |
0 |
- |
|
| TARS |
Tarsus Pharmaceuticals, I... |
Chief Commercial Officer |
• – – |
2023-03-17 |
4 |
S |
$13.28 |
$4,502 |
D/D |
(339) |
54,265 |
0 |
- |
|
| TARS |
Tarsus Pharmaceuticals, I... |
Chief Commercial Officer |
• – – |
2023-03-16 |
4 |
S |
$13.43 |
$4,512 |
D/D |
(336) |
54,604 |
0 |
- |
|
| TARS |
Tarsus Pharmaceuticals, I... |
Chief Commercial Officer |
• – – |
2023-03-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,790 |
54,940 |
0 |
- |
|
| TARS |
Tarsus Pharmaceuticals, I... |
Chief Commercial Officer |
• – – |
2022-11-15 |
4 |
AS |
$17.72 |
$121,506 |
D/D |
(6,857) |
49,729 |
0 |
- |
|
| TARS |
Tarsus Pharmaceuticals, I... |
Chief Commercial Officer |
• – – |
2022-08-24 |
4 |
OE |
$0.45 |
$48,879 |
D/D |
5,188 |
56,586 |
0 |
- |
|
| TARS |
Tarsus Pharmaceuticals, I... |
Chief Commercial Officer |
• – – |
2021-11-08 |
4 |
AS |
$28.11 |
$53,100 |
D/D |
(1,889) |
50,203 |
0 |
- |
|
| TARS |
Tarsus Pharmaceuticals, I... |
Chief Commercial Officer |
• – – |
2021-11-05 |
4 |
AS |
$28.11 |
$309 |
D/D |
(11) |
52,092 |
0 |
- |
|
| TARS |
Tarsus Pharmaceuticals, I... |
Chief Commercial Officer |
• – – |
2021-11-04 |
4 |
AS |
$28.03 |
$2,803 |
D/D |
(100) |
52,103 |
0 |
- |
|
| TARS |
Tarsus Pharmaceuticals, I... |
Chief Commercial Officer |
• – – |
2021-11-02 |
4 |
AS |
$26.75 |
$160,690 |
D/D |
(6,000) |
52,203 |
0 |
- |
|
| TARS |
Tarsus Pharmaceuticals, I... |
Chief Commercial Officer |
• – – |
2021-09-10 |
4 |
S |
$22.15 |
$57,435 |
D/D |
(2,593) |
58,203 |
0 |
- |
|
| TARS |
Tarsus Pharmaceuticals, I... |
Chief Commercial Officer |
• – – |
2021-09-10 |
4 |
OE |
$0.45 |
$48,973 |
D/D |
6,943 |
60,796 |
0 |
- |
|
| TARS |
Tarsus Pharmaceuticals, I... |
Chief Commercial OfficerOffice |
• – – |
2020-10-15 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
53,853 |
|
- |
|
| OPNT |
Opiant Pharmaceuticals In... |
Chief Commercial OfficerOffice |
• – – |
2019-09-20 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
13,500 |
|
- |
|
23 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
